A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
Status
Conditions
Details and patient eligibility
About
The goal of this observational study is to learn about the impact of HPV infection in women with intravenous leiomyomatosis(IVL). The main question it aims to answer is:
Does HPV infection promote the development of IVL from uterine leiomyoma? Surgical sections and HPV-DNA test results will be collected in participants diagnosed with IVL or uterine leiomyoma.
Full description
Previous proteomic studies have demonstrated that HPV infection-related proteins are more highly expressed in intravenous leiomyomatosis (IVL) compared to uterine leiomyoma (uML). Consequently, we conducted a case-control study to investigate the association between HPV and the development of IVL. We recruited adult patients diagnosed with either IVL or uML, collected their medical histories, surgical specimens from various sites, and HPV-DNA test results from cervical exfoliated cells, and performed subsequent statistical analyses and mechanistic investigations.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adult female patients with suspected IVL or uterine leiomyoma who receive surgery at PUMCH
- Be able to understand and sign the informed consent
Exclusion criteria
- Patients with other concurrent malignant tumors
- Pregnant or lactating female
- Postoperative pathology do not include IVL or uterine leiomyoma
Trial contacts and locations
Loading...
Central trial contact
Bao Liu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal